ArticleAnnals of surgical oncology2012

Novel C-terminal Hsp90 inhibitor for head and neck squamous cell cancer (HNSCC) with in vivo efficacy and improved toxicity profiles compared with standard agents.

Stephanie M Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.